NSEGeneral Updates1h ago · 31 Oct 2026, 08:14 pm

General Updates

Sun Pharmaceutical Industries Limited · SUNPHARMA

✦ AI SummaryFundraise

Sun Pharmaceutical Industries Limited has completed its postal ballot process, approving several special resolutions, including the Sun Pharma Employees Stock Option Plan 2026, provision of funds to the trust, and enhancement of borrowing limits.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Completion and Results of Postal Ballot dated 01 October 2026

Attachments (1)

📄

SUNSEC_31102026201341_SEIntimationforVR_-_31_October_2026.pdf

pdf

Download →
View document text
Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 31 October 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Completion and Results of Postal Ballot dated 01 October 2026 This is to inform you that the postal ballot process initiated pursuant to the notice dated 01 October 2026, wherein the voting period commenced on 02 October 2026, has been concluded today, i.e., 31 October 2026. Based on the Scrutinizer’s Report dated 31 October 2026, all the following Special Resolutions set out in the Postal Ballot Notice have been approved by the members of the Company with the requisite majority. Accordingly, the resolutions shall be deemed to have been passed on 31 October 2026, being the last date specified for e-voting. Item No. Particulars of Special Resolutions Approval of the Sun Pharma Employees Stock Option Plan 2026 (“ESOP 2026”) and Provision of Funds to the Trust 2. Approval of Secondary Acquisition of Equity Shares by the Trust 3. Approval for Extension of ESOP 2026 to Eligible Employees of Subsidiary Companies 4. Approval for Enhancement of Limits under Section 186 of the Companies Act, 2013 Approval for Enhancement of borrowing limit under Section 180(1)(c) of the Companies Act, 2013 6. Approval for Creation of Security under Section 180(1)(a) of the Companies Act, 2013 Approval for Creation of Encumbrance over Shares Pursuant to Regulation 24(5) of the SEBI Listing Regulations The voting results pursuant to Regulation 44(3) of the SEBI Listing Regulations is submitted separately in XBRL mode. The Scrutinizer’s Report is available on the website of the Company at www.sunpharma.com. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.